BIOSENSE WEBSTER INC QDOT-MICRO, BI-DIRECTIONAL, D-F CURVE, C3, SPLIT HANDLE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
|
Back to Search Results |
|
Catalog Number D139505 |
Device Problem
Contamination /Decontamination Problem (2895)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Type
malfunction
|
Event Description
|
It was reported that a patient underwent an ablation procedure with a qdot-micro, bi-directional, d-f curve, c3, split handle catheter and when pulling out the catheter to change sheaths, coagulation was observed under the pebax of the catheter tip.The catheter was in the right atrium.No ablation performed.The ngen pump was continuously running at 2ml/min.No error messages appeared.The catheter was changed, and the procedure was completed.There was no patient consequence.A vizigo small curve sheath was used during the procedure.There was no difficulty experienced while maneuvering the catheter or during the withdrawal.This event was originally assessed as not mdr reportable.The device was returned for analysis and revealed reddish material inside the pebax and a hole in its surface.The hole in the pebax makes this event mdr reportable.
|
|
Manufacturer Narrative
|
The event date is unknown.Device evaluation details: a picture was received for evaluation following biosense webster's procedures.According to pictures provided by the customer, reddish material was observed inside the pebax; however, there is no evidence of an external damage on the pebax.The customer complaint was confirmed based on the picture received.Additionally, the device was returned to biosense webster (bwi) for evaluation.Visual inspection of the returned device was performed following bwi procedures.Visual analysis revealed reddish material inside the pebax and a hole in its surface.The root cause of the damage on the pebax could not be conclusively determined, but it was concluded that it occurred outside the bwi manufacturing facilities and could be related to the failure described by the customer.All units are inspected prior to leaving the facility as there are functional tests and inspections at control points based on the process flow diagram (pfd) per its part number to avoid this type of damage from leaving the facility.A manufacturing record evaluation was performed for the finished device 30946635l number, and no internal actions related to the reported complaint condition were identified.The issue reported by the customer was confirmed.It should be noted that product failure is multifactorial.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This report is being submitted late due to a retrospective review of complaints for the qdot micro products.Biosense webster¿s investigation determined that upon approval of qdot in the united states on november 23, 2022, the electronic complaints system was not updated and therefore medical device reports were not submitted in a timely manner.Through biosense webster¿s investigation it was determined that this was an isolated case.An internal action was opened to address this issue.Manufacturer's ref.No: (b)(4).
|
|
Search Alerts/Recalls
|
|
|